• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙酮酸脱氢酶复合体与DNA/RNA结合蛋白YBX1协同调节细胞衰老和肿瘤发生。

The pyruvate dehydrogenase complex in concert with the DNA/RNA-binding protein YBX1 regulates cell senescence and tumorigenesis.

作者信息

Chen Huan, Shi Jing, Wang Qiuping, Liang Kunming, Pei Shaojun, Zhang Yi, Shi Xiang, Lv Jing, Xia Tian, Chen Di, Ma Yegang, Liu Hong-Xu, Piao Hai-Long

机构信息

State Key Laboratory of Phytochemistry and Natural Medicines, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China.

State Key Laboratory of Phytochemistry and Natural Medicines, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China; Department of Biochemistry & Molecular Biology, School of Life Sciences, China Medical University, Shenyang, China.

出版信息

J Biol Chem. 2025 Aug 12;301(9):110585. doi: 10.1016/j.jbc.2025.110585.

DOI:10.1016/j.jbc.2025.110585
PMID:40812419
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12446528/
Abstract

The activation of oncogenes is often accompanied by metabolic adaptations. The DNA/RNA-binding protein, Y-box binding protein 1 (YBX1), a well-known oncogene, is hyperactivated in nearly all cancer types. However, the metabolic hallmarks associated with YBX1 and the underlying mechanisms remain poorly understood. Here, we demonstrate that YBX1 sustains the activity of the pyruvate dehydrogenase (PDH) complex by regulating its catalytic alpha subunit, PDHA1. Mechanistically, YBX1 downregulates the expression of PDH kinases 1 and 4, leading to enhanced PDHA1 activity. Consequently, YBX1 deficiency results in significant impairment of pyruvate oxidation. Moreover, we found that YBX1, in conjunction with PDH activation, promotes epithelial cell senescence and suppresses cancer cell proliferation. These findings indicate that PDH activation imposes a constraint on the tumorigenic potential of YBX1.

摘要

癌基因的激活通常伴随着代谢适应。DNA/RNA结合蛋白Y盒结合蛋白1(YBX1)是一种著名的癌基因,在几乎所有癌症类型中都被过度激活。然而,与YBX1相关的代谢特征及其潜在机制仍知之甚少。在这里,我们证明YBX1通过调节其催化性α亚基PDHA1来维持丙酮酸脱氢酶(PDH)复合体的活性。从机制上讲,YBX1下调PDH激酶1和4的表达,导致PDHA1活性增强。因此,YBX1缺乏会导致丙酮酸氧化显著受损。此外,我们发现YBX1与PDH激活一起促进上皮细胞衰老并抑制癌细胞增殖。这些发现表明,PDH激活对YBX1的致瘤潜力施加了限制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/057a/12446528/680d560d761f/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/057a/12446528/31624f4cc3bf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/057a/12446528/81abaff7dae9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/057a/12446528/f6cfdc6b0d18/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/057a/12446528/15cd65e2f8d7/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/057a/12446528/5c2927423222/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/057a/12446528/680d560d761f/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/057a/12446528/31624f4cc3bf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/057a/12446528/81abaff7dae9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/057a/12446528/f6cfdc6b0d18/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/057a/12446528/15cd65e2f8d7/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/057a/12446528/5c2927423222/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/057a/12446528/680d560d761f/gr6.jpg

相似文献

1
The pyruvate dehydrogenase complex in concert with the DNA/RNA-binding protein YBX1 regulates cell senescence and tumorigenesis.丙酮酸脱氢酶复合体与DNA/RNA结合蛋白YBX1协同调节细胞衰老和肿瘤发生。
J Biol Chem. 2025 Aug 12;301(9):110585. doi: 10.1016/j.jbc.2025.110585.
2
Targeting YBX1: A novel therapeutic strategy for gastric cancer through regulation of cellular senescence and mTOR signaling.靶向YBX1:通过调节细胞衰老和mTOR信号通路治疗胃癌的新策略
Tissue Cell. 2025 Dec;97:103089. doi: 10.1016/j.tice.2025.103089. Epub 2025 Aug 14.
3
5-methylcytosine regulated CCNL2 promotes tumorigenesis and cisplatin resistance of ovarian cancer with therapeutic implications.5-甲基胞嘧啶调控的CCNL2促进卵巢癌的肿瘤发生及顺铂耐药并具有治疗意义。
J Ovarian Res. 2025 Jul 24;18(1):162. doi: 10.1186/s13048-025-01753-9.
4
TRIM31 triggers colorectal carcinogenesis and progression by maintaining YBX1 protein stability through ubiquitination modification.TRIM31通过泛素化修饰维持YBX1蛋白稳定性,从而引发结直肠癌的发生和进展。
Cell Death Dis. 2025 Aug 16;16(1):621. doi: 10.1038/s41419-025-07922-4.
5
Modulation of YBX1-mediated PANoptosis inhibition by PPM1B and USP10 confers chemoresistance to oxaliplatin in gastric cancer.PPM1B 和 USP10 通过调节 YBX1 介导的 PANoptosis 抑制作用赋予胃癌对奥沙利铂的化疗耐药性。
Cancer Lett. 2024 Apr 10;587:216712. doi: 10.1016/j.canlet.2024.216712. Epub 2024 Feb 15.
6
O-GlcNAcylation of YBX1 drives a glycolysis-histone lactylation feedback loop in hepatocellular carcinoma.YBX1的O-连接N-乙酰葡糖胺化驱动肝细胞癌中的糖酵解-组蛋白乳酰化反馈环。
Cancer Lett. 2025 Oct 28;631:217957. doi: 10.1016/j.canlet.2025.217957. Epub 2025 Jul 26.
7
YBX1 promotes 5-Fluorouracil resistance in gastric cancer via m5C-dependent ATG9A mRNA stabilization through autophagy.YBX1通过自噬依赖于m5C的ATG9A mRNA稳定作用促进胃癌对5-氟尿嘧啶的耐药性。
Oncogene. 2025 Apr 18. doi: 10.1038/s41388-025-03411-2.
8
NSUN2/YBX1 promotes the progression of breast cancer by enhancing HGH1 mRNA stability through mC methylation.NSUN2/YBX1 通过 mC 甲基化增强 HGH1 mRNA 稳定性促进乳腺癌的进展。
Breast Cancer Res. 2024 Jun 6;26(1):94. doi: 10.1186/s13058-024-01847-0.
9
The SOX12-YBX1-LDHA signaling axis drives metastasis in papillary thyroid carcinoma.SOX12-YBX1-LDHA信号轴驱动甲状腺乳头状癌转移。
Cell Death Dis. 2025 Jul 1;16(1):474. doi: 10.1038/s41419-025-07797-5.
10
YBX1/CD36 positive feedback loop-mediated lipid accumulation drives metabolic dysfunction-associated steatotic liver disease.YBX1/CD36 正反馈回路介导的脂质积累驱动代谢功能障碍相关脂肪性肝病。
Int J Biol Sci. 2025 Feb 18;21(5):2118-2134. doi: 10.7150/ijbs.105798. eCollection 2025.

本文引用的文献

1
Y-Box Binding Protein 1: Unraveling the Multifaceted Role in Cancer Development and Therapeutic Potential.Y 盒结合蛋白 1:揭开其在癌症发展中的多方面作用及其治疗潜力。
Int J Mol Sci. 2024 Jan 5;25(2):717. doi: 10.3390/ijms25020717.
2
Arginine reprograms metabolism in liver cancer via RBM39.精氨酸通过 RBM39 重编程肝癌中的代谢。
Cell. 2023 Nov 9;186(23):5068-5083.e23. doi: 10.1016/j.cell.2023.09.011. Epub 2023 Oct 6.
3
YBX1 as an oncogenic factor in T-cell acute lymphoblastic leukemia.YBX1 作为 T 细胞急性淋巴细胞白血病的致癌因子。
Blood Adv. 2023 Sep 12;7(17):4874-4885. doi: 10.1182/bloodadvances.2022009648.
4
Dichloroacetic acid and rapamycin synergistically inhibit tumor progression.二氯乙酸和雷帕霉素协同抑制肿瘤进展。
J Zhejiang Univ Sci B. 2023 May 15;24(5):397-405. doi: 10.1631/jzus.B2200356.
5
The evolution, evolvability and engineering of gene regulatory DNA.基因调控 DNA 的进化、可进化性与工程。
Nature. 2022 Mar;603(7901):455-463. doi: 10.1038/s41586-022-04506-6. Epub 2022 Mar 9.
6
Upregulated YB-1 protein promotes glioblastoma growth through a YB-1/CCT4/mLST8/mTOR pathway.YB-1 蛋白上调通过 YB-1/CCT4/mLST8/mTOR 通路促进胶质母细胞瘤生长。
J Clin Invest. 2022 Apr 15;132(8). doi: 10.1172/JCI146536.
7
YBX1 mediates translation of oncogenic transcripts to control cell competition in AML.YBX1 通过介导致癌转录本的翻译来控制 AML 中的细胞竞争。
Leukemia. 2022 Feb;36(2):426-437. doi: 10.1038/s41375-021-01393-0. Epub 2021 Aug 31.
8
The requirement for pyruvate dehydrogenase in leukemogenesis depends on cell lineage.丙酮酸脱氢酶在白血病发生中的需求取决于细胞谱系。
Cell Metab. 2021 Sep 7;33(9):1777-1792.e8. doi: 10.1016/j.cmet.2021.07.016. Epub 2021 Aug 9.
9
YB1 regulates miR-205/200b-ZEB1 axis by inhibiting microRNA maturation in hepatocellular carcinoma.YB1 通过抑制肝癌中 microRNA 的成熟来调节 miR-205/200b-ZEB1 轴。
Cancer Commun (Lond). 2021 Jul;41(7):576-595. doi: 10.1002/cac2.12164. Epub 2021 Jun 10.
10
YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner.YBX1 通过调节 BCL2 的稳定性依赖于 m6A 方式维持髓系白血病细胞的存活。
Blood. 2021 Jul 8;138(1):71-85. doi: 10.1182/blood.2020009676.